Essential Partners »

Aktis Oncology shares owned by Essential Partners

Quarter-by-quarter ownership of Aktis Oncology (AKTS) shares owned by Essential Partners from 13F filings

Historical chart of Essential Partners investment in Aktis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Aktis Oncology held by Essential Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aktis Oncology by Essential Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $129 4 32.25

More positions owned by Essential Partners

Sprott Gold Convert to Physical Cef (PHYS)
Vanguard Short-Term USTS Etf (VGSH)
iShares S&P 500 Etf (IVV)
Schwab Fundamental Int'l Broad Etf (FNDF)
Schwab Fundamental U.S. Broad Etf (FNDB)
iShares 0-3 Month T-Bills ETF Etf (SGOV)
iShares Core MSCI Emerging Markets Etf (IEMG)
iShares MSCI Emerging Markets Ex-China Etf (EMXC)
Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
GMO US Value Etf (GMOV)
Micron Technology Stock (MU)
Comfort Sys Usa Stock (FIX)
Energy ETF Etf (XLE)
Schwab International Etf (SCHF)

View all positions for Essential Partners

Top funds holding Aktis Oncology

MPM Oncology Impact Management
EcoR1 Capital
Blue Owl Capital Holdings
BlackRock
Wellington Management Company
Rtw Investments
T. Rowe Price Associates
Henderson Group
RA Capital Management
Jupiter Topco
Baker Bros. Advisors
Octagon Capital Advisors
Merck & Co
Vanguard Capital Management
TCG Crossover Management

View all funds holding Aktis Oncology